Spread the love

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Vitamin-based therapy for cancer: 1α,25-dihydroxyvitamin D(3) suppresses the expression of cell cycle regulatory protein CCNA2 via up regulation of its target gene, 21/January/20145, 12.14 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests that 1α,25-dihydroxyvitamin D(3), by increasing the expression of its target gene, it may suppress the expression of Cyclin A2 and inhibit the proliferation of cells.  Thereby, it may promote tumor suppression.  Thus, pharmacological formulations encompassing “1α,25-dihydroxyvitamin D(3) or its analogues”  may be used to inhibit the progression of human tumors

Amount: $ 300

Undisclosed information: How 1α,25-dihydroxyvitamin D(3) suppresses the expression of Cyclin A2

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Spread the love